NCT07236996 Evaluation of the Health Effects of the Air Purifier in Preterm Infants After Discharge
| NCT ID | NCT07236996 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| Condition | Premature - Weight 1000g-2499g or Gestation of 28-37weeks |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2021-05-21 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2021-05-21 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Participant's baby was born prematurely and had underdeveloped lungs at birth. Most premature infants require mechanical ventilation after birth, which increases the risk of lung injury and may lead to varying degrees of bronchopulmonary dysplasia (BPD). Investigators believe that introducing an air purifier into your home environment after Participant's baby is discharged could help improve their lung development. This study aims to non-invasively measure baby's transcutaneous carbon dioxide (PtcCO₂) levels and blood oxygen saturation (SpO₂) at home, both with and without the use of an air purifier. In addition, investigators will collect data from Kaohsiung Medical University Hospital medical records regarding the number of visits, respiratory status, height, weight, head circumference, and developmental progress. Health questionnaires will also be administered to assess changes in health outcomes and provide recommendations on improving indoor air quality in Participant's home.
Eligibility Criteria
Inclusion Criteria:Children aged 0 to 6 years who were born at less than 37 weeks of gestation. \- Exclusion Criteria:Children born at more than 37 weeks of gestation. \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07236996 clinical trial?
This trial is open to participants of all sexes, up to 6 Years, studying Premature - Weight 1000g-2499g or Gestation of 28-37weeks. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07236996 currently recruiting?
Yes, NCT07236996 is actively recruiting participants. Contact the research team at ch840062@cc.kmu.edu.tw for enrollment information.
Where is the NCT07236996 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT07236996 clinical trial?
NCT07236996 is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. The trial plans to enroll 180 participants.